Back to Search
JEFF HOOD, M.D.
M.D.
Anesthesiology Physician
NPI: 1861481954IndividualAccepts Medicare
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
19894(OK)
CMS Specialties
PrimaryANESTHESIOLOGY
Education
UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE
Class of 1995
Research & Publications (20)
The pregnant health care worker--an evidence-based approach to job assignment and reassignment.
PMID 18717297·AAOHN J·2008
6-review
Pertussis update--an occupational health perspective for the 21st century.
PMID 18293595·AAOHN J·2008
6-review
Jak2 inhibition deactivates Lyn kinase through the SET-PP2A-SHP1 pathway, causing apoptosis in drug-resistant cells from chronic myelogenous leukemia patients.
PMID 19234487·Oncogene·2009
7-preclinical
Consumer involvement in the South Australian state policy for planned home birth.
PMID 19278387·Birth·2009
8-other
Service-learning in dental education: meeting needs and challenges.
PMID 19339432·J Dent Educ·2009
6-review
Selective inhibition of JAK2-driven erythroid differentiation of polycythemia vera progenitors.
PMID 18394555·Cancer Cell·2008
7-preclinical
Retinal vascular permeability suppression by topical application of a novel VEGFR2/Src kinase inhibitor in mice and rabbits.
PMID 18483622·J Clin Invest·2008
7-preclinical
Comparison of the immunostimulatory and proinflammatory activities of candidate Gram-positive endotoxins, lipoteichoic acid, peptidoglycan, and lipopeptides, in murine and human cells.
PMID 18468694·Immunol Lett·2008
4-observational
Results of a multicentre randomised controlled trial of statistical process control charts and structured diagnostic tools to reduce ward-acquired meticillin-resistant Staphylococcus aureus: the CHART Project.
PMID 18723251·J Hosp Infect·2008
4-observational
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera.
PMID 18394554·Cancer Cell·2008
7-preclinical
Topical administration of a multi-targeted kinase inhibitor suppresses choroidal neovascularization and retinal edema.
PMID 18330892·J Cell Physiol·2008
7-preclinical
TG101348, a JAK2-selective antagonist, inhibits primary hematopoietic cells derived from myeloproliferative disorder patients with JAK2V617F, MPLW515K or JAK2 exon 12 mutations as well as mutation negative patients.
PMID 18354492·Leukemia·2008
8-other
Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis.
PMID 18508974·Proc Natl Acad Sci U S A·2008
7-preclinical
Fish distributions and nutrient cycling in streams: can fish create biogeochemical hotspots?
PMID 18724743·Ecology·2008
7-preclinical
Decreased differentiation of erythroid cells exacerbates ineffective erythropoiesis in beta-thalassemia.
PMID 18480424·Blood·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1921 STONECIPHER BLVD
ADA, OK 74820 - Phone
- (580) 421-4570
Quick Facts
- NPI
- 1861481954
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile